49th week of 2012 patent applcation highlights part 57 |
Patent application number | Title | Published |
20120309962 | PROCESS FOR THE PREPARATION OF CALCOBUTROL - The invention concerns a process for the preparation of the calcium complex of 0-(2,3-Dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclodecane-4,7-triacetic acid, also known as Calcobutrol, starting from the pure gadolinium complex (Gadobutrol). The invention furthermore concerns Calcobutrol with a hitherto unknown level of purity. | 2012-12-06 |
20120309963 | 5-CYANO-4- (PYRROLO [2,3B] PYRIDINE-3-YL) -PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 2012-12-06 |
20120309964 | CYCLIC AMINE COMPOUND AND ACARICIDE - The present invention provides a cyclic amine compound represented by formula (I) (in formula (I), Cy | 2012-12-06 |
20120309965 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | 2012-12-06 |
20120309966 | 8-METHYL-1-PHENYL-IMIDAZOL[1,5-A]PYRAZINE COMPOUNDS - The present invention provides 8-methyl-1-phenyl-imidazo[1,5-a]pyrazine deriva-tives according to formula I or pharmaceutically acceptable salts thereof. The compounds of the current invention show inhibitory activity against Lck and can be used for the treatment of Lck-mediated diseases or Lck-mediated conditions such as inflammatory disorders. | 2012-12-06 |
20120309967 | LIGHT-EMITTING MATERIAL COMPRISING ORTHOMETALATED IRIDIUM COMPLEX, LIGHT-EMITTING DEVICE, HIGH EFFICIENCY RED LIGHT-EMITTING DEVICE, AND NOVEL IRIDIUM COMPLEX - A light-emitting material comprises iridium and at least one ligand represented by the following formula: | 2012-12-06 |
20120309968 | POLYMORPHS OF DASATINIB, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS THEREOF - Polymorph I of dasatinib monohydrate and Polymorph II of dasatinib, their preparation methods and pharmaceutical compositions containing the same are provided. These polymorphs have better physicochemical properties, are more stable and are more suitable for industrial scale production. | 2012-12-06 |
20120309969 | SOLID FORMS OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-1-YL-[5-METHANESUL- FONYL-2-((S)-2,2,2-TRIFLUORO-1-METHYL-ETHOXY)-PHENYL]-METHANONE - The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions. The compounds of present invention are suitable for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease. | 2012-12-06 |
20120309970 | PLATINUM COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE - An organic electroluminescent device is provided and has at least one organic layer between a pair of electrodes. The organic compound contains a compound represented by the following formula (I): | 2012-12-06 |
20120309971 | Synthetic method of organometallic iridium compound - A synthetic method for preparing organometallic iridium compounds is provided and includes the two steps of (1) synthesizing a di-iridium compound with a halogenated bridge: L | 2012-12-06 |
20120309972 | TETRAZOLYLOXIME DERIVATIVE OR SALT THEREOF AND FUNGICIDE - There are provided a tetrazolyloxime derivative, a salt thereof, and a fungicide, that have excellent control effects against plant diseases. The fungicide contains, as an active ingredient, at least one selected from the group consisting of tetrazolyloxime derivatives represented by formula (6) and salts thereof. In formula (6), X represents a halogen atom, A represents a tetrazolyl group, R represents a halogen atom or the like, D represents a single bond or an oxygen atom, E represents a single bond or an alkylene chain, R | 2012-12-06 |
20120309973 | PREPARATION OF 2-(4-BROMOPHENYL)-2-METHYLPROPANOIC ACID - Selective bromination of 2-methyl-2-phenylpropanoic acid in aqueous medium is described to obtain pure 2-(4-bromophenyl)-2-methylpropanoic acid, which is a useful key intermediate in the process of manufacturing pure fexofenadine. | 2012-12-06 |
20120309974 | Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials - The present invention relates to Aromatic ring substituted dianthracene compounds and pertains to the field of synthesis of organic light-emitting materials. Aromatic ring substituted dianthracene compounds in the formula (I) present high glass transition temperature and solution efficiency, which can be used as effective blue-light emitting host materials. | 2012-12-06 |
20120309975 | PPAR-SPARING THIAZOLIDINEDIONE SALTS FOR THE TREATMENT OF METABOLIC DISEASES - The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease). | 2012-12-06 |
20120309976 | PREPARATION PROCESS OF THE SODIUM SALT OF ESOMEPRAZOLE - A preparation process of esomeprazole sodium substantially free of sulfone impurity including the steps of: a) combining either esomeprazole with a (C | 2012-12-06 |
20120309977 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES - Disclosed are processes for preparing [(3-hydroxypyridine-2-carbonyl)amino]-alkanoic acids, derivatives, inter alia, 5-aryl substituted and 5-heteroaryl substituted [(3-hydroxypyridine-2-carbonyl]aminolacetic acids. Further disclosed are methods for making prodrugs of [(3-hydroxypyridine-2-carbonyl)-amino]acetic acids, for example, [(3-hydroxypyridine-2-carbonyl]amino}acetic acid esters and {[3-hydroxypyridine-2-carbonyl]amino}acetic acid amides. The disclosed compounds are useful as prolyl hydroxylase inhibitors or for treating conditions wherein prolyl hydroxylase inhibition is desired. | 2012-12-06 |
20120309978 | ALPHA-CRYSTALLINE FORM OF CARBABENZPYRIDE - The present invention relates to a new crystalline form of carbabenzpyride of formula (I) and the process for its preparation. Further, the invention relates to the use of this new crystalline form of carbabenzpyride in the treatment and prevention of viral infections. | 2012-12-06 |
20120309979 | PHOSPHORESCENT MATERIAL, THEIR PREPARATIONS AND APPLICATIONS - The subject invention is directed to tetradentate bis-(NHC carbenes) alkylene ligand Pt(II) complexes, tetradentate bis-(NHC carbenes) alkylene ligands, and its ligand precursors, for preparation of the Pt(II) complexes. The Pt(II) complexes show a deep blue emission with an improved quantum efficiency and can be used for fabrication of OLEDs with an electroluminescence layer that comprise the bis-(NHC carbenes) alkylene ligand Pt(II) complexes. | 2012-12-06 |
20120309980 | ORGANIC ELECTROLUMINESCENCE DEVICE - A compound is represented by the following formula (I): | 2012-12-06 |
20120309981 | PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES - The invention relates to a process for the preparation of salts having perfluoroalkyltricyano- or perfluoroalkylcyanofluoroborate anions, ((per)fluoro)phenyltricyano- or ((per)fluoro)phenylcyanofluoroborate anions, phenyltricyanoborate anions which are mono- or disubstituted by perfluoroalkyl groups having 1 to 4 C atoms or phenylcyanofluoroborate anions which are mono- or disubstituted by perfluoroalkyl groups having 1 to 4 C atoms, by reaction of alkali metal trifluoroperfluoroalkylborate with trialkylsilyl cyanide and a subsequent salt-exchange reaction or by direct reaction of an organic trifluoroperfluoroalkyl borate with trialkylsilyl cyanide. | 2012-12-06 |
20120309982 | ELECTROLYTE FORMULATIONS - The present invention relates to electrolyte formulations comprising at least one compound of formula (I) M | 2012-12-06 |
20120309983 | AMINO ACID GROUP-MODIFIED ORGANOPOLYSILOXANE AND SILANE, AMINO ACID GROUP-CONTAINING COMPOUND, AND PRODUCTION METHOD THEREOF - An amino acid-modified organopolysiloxane is provided. It has an amino acid derivative bonded to at least one silicon atom of the organopolysiloxane segment constituting the backbone of the organopolysiloxane via an amide bond represented by the following general formula (1): | 2012-12-06 |
20120309984 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE - Objects of the present invention are to provide novel anthracene derivatives and novel organic compounds; a light-emitting element that has high emission efficiency; a light-emitting element that is capable of emitting blue light with high luminous efficiency; a light-emitting element that is capable of operation for a long time; and a light-emitting device and an electronic device that have lower power consumption. An anthracene derivative represented by a general formula (1) and an organic compound represented by a general formula (17) are provided. A light-emitting element that has high emission efficiency can be obtained by use of the anthracene derivative represented by the general formula (1). Further, a light-emitting element that has a long life can be obtained by use of the anthracene derivative represented by the general formula (1). | 2012-12-06 |
20120309985 | 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS - In one aspect, the invention relates to compounds of formula I: | 2012-12-06 |
20120309986 | PROCESS FOR THE PREPARATION OF CHYMASE MODULATORS - The present invention is a process for the preparation of chymase modulators, useful in the treatment of inflammatory and serine protease mediated disorders. | 2012-12-06 |
20120309987 | METHOD FOR PRODICING EPISULFIDE COMPOUND - A problem to be solved by the present invention is to provide an episulfide compound efficiently from an epoxy compound with no need of a measure against odor or corrosion, or a neutralization step. The present invention solved the above-described problem by a method for producing an episulfide compound in which an epoxy compound and a thiourea are reacted with each other in the presence of an ammonium compound. | 2012-12-06 |
20120309988 | INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B - Intermediates and methods of their use in the synthesis of anslogs of halichondrin B are provided. | 2012-12-06 |
20120309989 | CONTINUOUS PROCESS FOR THE PRODUCTION OF BETA-KETO ESTERS BY CLAISEN CONDENSATION - The invention concerns A continuous process for the production of compounds having the general formula (6): | 2012-12-06 |
20120309990 | Processes for the Purification of Lubiprostone - There is provided processes for purification of Lubiprostone by formation of amine salts. Also provided are compounds of the Lubiprostone amine salt. Also provided are compositions comprising Lubiprostone and amines. | 2012-12-06 |
20120309991 | METHODS FOR EXTRACTING COCOA PROCYANIDINS AND EXTRACTS THEREOF - A cocoa extract which is rich in procyanidin monomers and oligomers is made by extracting de-fatted, unroasted, unfermented cocoa beans with organic solvents. The yield of procyanidins in an extract varies with type of solvent used, reaction temperature, reaction pH and whether or not the solvent is an aqueous solution. Extraction parameters can be optimized to increase procyanidin yield, and different conditions result in the preferential extraction of the higher or lower oligomers. A preferred extraction method is counter-current extraction method. | 2012-12-06 |
20120309992 | PROCESS FOR IMPROVING THE SELECTIVITY OF AN EO CATALYST - The present invention relates to a process for improving the overall selectivity of an EO process for converting ethylene to ethylene oxide utilizing a highly selective EO silver catalyst containing a rhenium promoter wherein following normal operation a hard strip of the chloride on the surface of the catalyst is conducted in order to remove a portion of the chlorides on the surface of the catalyst. Following the hard strip, the catalyst is optionally re-optimized. Surprisingly, it has been found that the selectivity of the catalyst following the hard strip may be substantially higher than the selectivity prior to the hard strip. | 2012-12-06 |
20120309993 | CATALYST FOR ESTERAMINE PRODUCTION - Provided are methods for decreasing the reaction time between an alkanolamine such as triethanolamine and a fatty acid alkyl ester such as, a triglyceride, a vegetable oil, a methyl ester, an ethyl ester, etc., a fatty acid, or a mixture thereof The methods utilize a divalent zinc catalyst to facilitate and accelerate an esterification or transesterification reaction between the alkanolamine and the fatty acid, or fatty acid alkyl ester. | 2012-12-06 |
20120309994 | Use of Propylene Oxide Adducts - Suggested is the use of adducts of 2 to 50 moles propylene oxide to hydroxy carboxylic acids as monomer or co-monomer components in the production of polyesters and polyurethanes or reactive solvents for polymers. | 2012-12-06 |
20120309995 | PROCESSES FOR PREPARATION OF OIL COMPOSITIONS - The present invention is directed to processes for preparing oil compositions having a high concentration of poly-unsaturated fatty acids and oil compositions having a low concentration of α-linolenic acid. In addition, the present invention is directed to processes for preparing oil compositions having advantageous stability characteristics. | 2012-12-06 |
20120309996 | COSMETIC COMPOSITION CONTAINING POLYGLYCEROL PARTIAL ESTER - The present invention relates to cosmetic compositions containing polyglycerol partial esters of linear, unsubstituted carboxylic acids and bifunctional carboxylic acids with the provisos that the polyglycerol partial ester comprises an HLB-value from 2 to 10 and that the polyglycerol obtained by hydrolysis or alcoholysis of the polyglycerol partial ester comprises an average degree of polymerization of from 2 to 8 and at least 1% of the polyglycerol comprises cyclic structures. The present invention also relates to the use of aforementioned polyglycerol esters for the production of and use in cosmetic compositions. | 2012-12-06 |
20120309997 | Enantiomerically Enriched Aminodiphosphines as Ligands for the Preparation of Catalysts for Asymmetric Synthesis - The present invention relates to enantiomerically enriched aminodiphosphine ligands where the chirality is located in the phosphorus atom and their preparation process, to catalysts containing them and their preparation process, as well as their use in asymmetric synthesis. | 2012-12-06 |
20120309998 | Novel Class of Olefin Metathesis Catalysts, Methods of Preparation, and Processes For the Use Thereof - This invention relates to a metathesis catalyst comprising a Group 8 metal complex represented by the formula: | 2012-12-06 |
20120309999 | AMMONIUM FLUORIDE CHEMISTRIES - A method of removing at least a portion of a silicon oxide material is disclosed. The silicon oxide is removed by exposing a semiconductor structure comprising a substrate and the silicon oxide to an ammonium fluoride chemical treatment and a subsequent plasma treatment, both of which may be effected in the same vacuum chamber of a processing apparatus. The ammonium fluoride chemical treatment converts the silicon oxide to a solid reaction product in a self-limiting reaction, the solid reaction product then being volatilized by the plasma treatment. The plasma treatment includes a plasma having an ion bombardment energy of less than or equal to approximately 20 eV. An ammonium fluoride chemical treatment including an alkylated ammonia derivative and hydrogen fluoride is also disclosed. | 2012-12-06 |
20120310000 | ROSUVASTATIN CALCIUM INTERMEDIATE AND METHOD FOR PREPARING THE SAME - A method for preparing a rosuvastatin calcium intermediate, including a) contacting a halogenated ethene with magnesium metal to obtain a halogenated ethene Grignard reagent, and carrying out a Grignard reaction between the halogenated ethene Grignard reagent and R-epichlorohydrin; b) adding sodium cyanide for carrying out a nucleophilic substitution reaction; c) adding alcohol for carrying out an alcoholysis reaction; d) adding a basic solvent for carrying out protection of a first hydroxyl group; e) selectively oxidizing a second hydroxyl group; and f) adding triphenylphosphine in alkaline condition for carrying out a Wittig reaction. | 2012-12-06 |
20120310001 | METHOD OF PRODUCING BASE COMPOUND FOR LIQUID FLUOROELASTOMER - A method of producing a base compound for a liquid fluoroelastomer which is unaffected by the storage state of the added silica powder, and yields minimal fluctuation in the viscosity between production lots. Specifically, a method of producing a base compound for a liquid fluoroelastomer containing:
| 2012-12-06 |
20120310002 | 1,4,6,10-Tetra-Double Bond Pentadec-Carbon Phosphonate, Preparation Method Thereof, And Preparation Method Of Lycopene Using The Same - 1,4,6,10-tetra-double bond pentadec-carbon phosphonate of formula (4), and preparation method thereof are provided. The preparation method comprises: reacting a pseudo ionone of formula (2) with sulfonium salt to prepare a epoxide of formula (9), and then reacting the epoxide of formula (9) with magnesium bromide to prepare a C-14 aldehyde of formula (3); condensing the C-14 aldehyde of formula (3) with tetra-alkyl methylene diphosphonate to obtain 1,4,6,10-tetra-double bond pentadec-carbon phosphonate of formula (4). Furthermore, the preparation method of lycopene via 1,4,6,10-tetra-double bond pentadec-carbon phosphonate of formula (4) is also provided. The present method has the advantages of short route, easily obtained raw materials, and low cost. | 2012-12-06 |
20120310003 | METHOD FOR PRODUCING CYANOALKENYLCYCLOPROPANECARBOXYLIC ACID SALT - A method for producing a salt of an amine with a cyanoalkenylcyclopropanecarboxylic acid, the method comprising a first step of mixing a carboxylic acid compound represented by formula (2C) and at least one amine selected from the group consisting of primary amines and secondary amines in an organic solvent; a second step of depositing a salt of the amine with a cyanoalkenylcyclopropanecarboxylic acid represented by formula (2) from the mixture obtained in the first step; and a third step of recovering the salt deposited in the second step; | 2012-12-06 |
20120310004 | NONYL ALCOHOLS WITH A LOW DEGREE OF BRANCHING AND THEIR DERIVATIVES - The invention relates to nonyl alcohols with a low degree of branching and derivatives produced using them. In particular the present invention relates to mixture of primary nonyl alcohols in which at least 80% of the alkyl chains are linear and at least 15% of the alkyl chains are branched at the 2-carbon position and its derivatives. The low degree of branching produces derivatives that are more elongated and less bulky that similar derivatives produced with more highly branched alcohols. | 2012-12-06 |
20120310005 | METHOD FOR PRODUCING 2-AZAADAMANTANE - To provide a method whereby a 2-azaadamantane can easily be obtained in good yield. | 2012-12-06 |
20120310006 | PROCESS FOR PRODUCING ALLYL ACETATE - A process for producing allyl acetate is disclosed. The process comprises reacting a feed comprising propylene, acetic acid, oxygen, and carbon dioxide in the presence of a supported palladium catalyst. The feed comprises from 2 to 6 mole percent carbon dioxide, which improves the selectivity to allyl acetate. | 2012-12-06 |
20120310007 | Method for Producing Vinyl Acetate - A method for producing vinyl acetate in a heterogeneously catalyzed, continuous gas phase process by reacting ethylene with acetic acid and oxygen in a reactor and separating the product gas stream substantially comprising ethylene, vinyl acetate, acetic acid, water, carbon dioxide and inert gases. | 2012-12-06 |
20120310008 | PROCESS FOR PREPARING 2,5-DIHYDROXYTEREPHTHALIC ACID - The present invention provides a process for preparing 2,5-dihydroxyterephthalic acid which comprises reacting a dialkali metal salt of hydroquinone with carbon dioxide in a reaction medium in the presence of a potassium salt represented by formula (I): | 2012-12-06 |
20120310009 | Process for the Production of Acetic Acid - The disclosure relates to a process in which methanol is carbonylated in a reaction zone in the presence of a catalyst to obtain a reaction mixture (A) comprising acetic acid, hydrogen iodide, methyl iodide, water and the catalyst. At least a part of the reaction mixture (A) is withdrawn from the reaction zone. The withdrawn part of the reaction mixture (A) is introduced into a flash zone where it is brought into contact with an alkylimidazolium iodide to form a secondary mixture (B), and where the secondary mixture (B) is separated to obtain a vapor stream (B | 2012-12-06 |
20120310010 | Method for producing sulfonamides - A process for preparing sulfonamides I | 2012-12-06 |
20120310011 | PREPARATION OF BORON CROSSLINKING AGENTS FOR FRACTURING FLUIDS - Methods for making polyaminoboric acid compounds are provided. The polyaminoboric acid compounds are made by reacting a polyamine with boric acid in the presence of a solvent to produce polyaminoboric acid compounds with more than one boron-nitrogen bond. The polyaminoboric acid compounds are useful as crosslinking agents for fracturing fluids. | 2012-12-06 |
20120310012 | METHOD FOR PREPARING A DEPEROXIDATION CATALYST - A process for preparing a deperoxidation catalyst comprising chromium as the main catalytic element is described. Also described, is a process for preparing an organic solution of a chromic acid ester. The solution can be used as a catalyst in a deperoxidation of an alkyl peroxide in a process for manufacturing cyclohexanol/cyclohexanone by oxidation of cyclohexane. | 2012-12-06 |
20120310013 | 5-NORBORNENE-2-SPIRO-a-CYCLOALKANONE-a'-SPIRO-2''-5''-NORBORNENE AND METHOD FOR PRODUCING THE SAME - A 5-norbornene-2-spiro-α-cycloalkanone-α′-spiro-2″-5″-norbornene represented by the following general formula (1): | 2012-12-06 |
20120310014 | TREATMENT OF BISPHENOL-A RESIDUE STREAMS - In a method of treating a residue stream from the production of bisphenol-A, the residue stream is contacted with an aqueous solution of a base under conditions effective to hydrolyze at least part of said residue stream into acetone and phenol and produce an effluent stream. Acetone is recovered from the effluent stream to produce a phenol-containing mixed phase stream which is substantially free of acetone and which contains water and unhydrolyzed heavy organic compounds. The phenol-containing mixed phase stream is then treated with a water-immiscible organic solvent to extract phenol and unhydrolyzed heavy organic compounds into said solvent and produce an organic phase containing the solvent, phenol and unhydrolyzed heavy aromatic compounds and an aqueous phase with reduced concentrations of phenol and unhydrolyzed heavy organic compounds. At least part of the phenol and the organic solvent are subsequently recovered from the organic phase. | 2012-12-06 |
20120310015 | RECOVERY OF PHENOL AND ACETONE FROM BISPHENOL-A STREAMS - In a method of recovering phenol and acetone from a feed stream containing bisphenol-A and isomers thereof, the feed stream is contacted with water and a source of hydroxyl ions under conditions effective to decompose at least part of said bisphenol-A and isomers thereof to phenol and acetone. The conditions include a temperature of about 150° C. to about 300° C., a pressure sufficient to keep the water substantially in the liquid phase at said temperature, and a molar ratio of hydroxyl ions to hydroxyphenyl groups in the residue stream from about 0.3:1 to about 0.9:1. | 2012-12-06 |
20120310016 | PROCESS FOR SYNTHESIS OF ACROLEIN - An object of the present invention is to provide a technology which can suppress the blockage and abrasion of pipes and devices caused by the production of by-products and stably synthesize acrolein at a high yield, under a condition in which energy efficiency is improved by an elevated concentration of glycerol in a reaction liquid, in a process for synthesis of acrolein by reacting supercritical water and an acid with glycerol. An embodiment of the present invention includes: setting a concentration of glycerol in the reaction liquid at 30% by weight or lower; also cooling the reaction liquid to a temperature between a temperature (300° C. or lower) at which the reaction stops and a temperature (100° C. or higher) at which tar contained in the reaction liquid can keep a state in which its viscosity is sufficiently low; then separating and removing carbon particles from the reaction liquid; subsequently cooling the reaction liquid to a temperature which is a boiling point of water or lower and at which the tar component in the reaction liquid does not adhere to devices; and then decompressing the cooled reaction liquid. | 2012-12-06 |
20120310017 | METHOD FOR OXIDIZING HYDROCARBONS WITH OXYGEN - A method for oxidizing saturated hydrocarbons with oxygen, preferably saturated cyclic hydrocarbons such as cyclohexane, to produce alkyl hydroperoxide is described. A method for oxidizing saturated hydrocarbons with oxygen in a plurality of consecutive steps to control the rate of the reaction and obtain a high degree of alkyl hydroperoxide selectivity is also described. The described methods can relate to methods for condensing oxidation gases recovered in an oxidation reactor and recycling thereof. | 2012-12-06 |
20120310018 | ZEOLITIC IMIDAZOLATE FRAMEWORK MEMBRANES AND METHODS OF MAKING AND USING SAME FOR SEPARATION OF C2- AND C3+ HYDROCARBONS AND SEPARATION OF PROPYLENE AND PROPANE MIXTURES - Certain embodiments are directed to processes for fabrication of zeolitic imidazolate framework (ZIF) membranes. These ZIF membranes can be used in separating C2-hydrocarbons from C3+ hydrocarbons and propylene/propane mixtures. | 2012-12-06 |
20120310019 | Isomerization of 1,1,3,3-Tetrafluoropropene - The present invention involves methods for isomerization of 1234zc. Also provided are methods for managing 1,1,3,3-tetrafluoropropene produced as a byproduct in a process for synthesizing trans-1,3,3,3-tetrafluoropropene from 245fa, wherein 1234zc is converted into trans/cis-1234ze with the help of a catalyst in the absence of HF and in an isomerization reactor, or is converted into 1234zc and/or 245fa with the help of a catalyst in the presence of HF in a separate reactor or preferably in the same reactor of 245fa dehydrofluorination. | 2012-12-06 |
20120310020 | METHOD FOR AVOIDING THE GENERATION OF BY-PRODUCTS DURING THE PRODUCTION OF HALOALKANE COMPOUNDS - Disclosed is a process for the manufacture of haloalkane compounds, and more particularly, to an improved process for the manufacture of the compound 1,1,1,3,3-pentachloropropane (HCC-240fa), which mitigates the formation of by-products. The present invention is also useful in the manufacture of other haloalkane compounds such as HCC-250 and HCC-360. One embodiment of the process comprises a method and system for avoiding the formation of polyvinyl chloride during the production of HCC-240fa from CC1 | 2012-12-06 |
20120310021 | METHOD FOR MITIGATING THE FORMATION OF BY-PRODUCTS DURING THE PRODUCTION OF HALOALKANE COMPOUNDS - Disclosed is a process for the manufacture of haloalkane compounds, and more particularly, an improved process for the manufacture of the compound 1,1,1,3,3-penta-chloropropane (HCC-240fa), which mitigates the formation of by-products from vinyl chloride (CH | 2012-12-06 |
20120310022 | Compositions And Methods For Inhibiting Naphthenate Solids Formation From Liquid Hydrocarbons - The present invention relates to a composition and method for inhibiting the formation of naphthenate solids in a liquid hydrocarbon. The method includes contacting a composition including a rosin amine having a formula (I): or (II): where formula (AA): represents a single or double bond; R1, R2 and R5 each independently represent H, alkyl, alkenyl or an alkynyl group each having between one and ten carbon atoms, —(R3O)nR4 wherein R3 is an alkyl group having 1 to 3 carbon atoms and R4 is H, alkyl, alkenyl or an alkynyl group each having between one and ten carbon atoms; n is an integer between 5 and 50; X is a halide, sulphate, phosphate or acetate ion; and a demulsifier intermediate with the liquid hydrocarbon. | 2012-12-06 |
20120310023 | Methods of Producing Liquid Hydrocarbon Fuels from Solid Plastic Wastes - Embodiments of the present disclosure provide methods of producing high quality liquid fuels from solid plastic waste, high quality liquid fuels, and the like. | 2012-12-06 |
20120310024 | Dealkylation Process - In a process for dealkylating a poly-alkylated aromatic compound, a feed comprising at least one poly-alkylated aromatic compound selected from polypropylbenzene, polybutylbenzene, and polycyclohexylbenzene is introduced into a reaction zone. The feed is then contacted in the reaction zone with an acid catalyst under conditions effective to dealkylate at least a portion of the poly-alkylated aromatic compound and produce a first reaction product comprising at least one mono-alkylated aromatic compound. | 2012-12-06 |
20120310025 | Catalyst for Synthesizing 1-Hexene from Ethylene Trimerization and Application Thereof - A catalyst for synthesizing 1-hexene from ethylene trimerization and its application are provided. Said catalyst consists of (a) the compound containing P and N, (b) electron donor, (c) Cr compound, (d) carrier and (e) accelerator. The molar ratio of (a), (b), (c), (d) and (e) is 0.5-100:0.5-100:1:0.5-10:50-5000. The catalyst is prepared by mixing the components of (a)-(e) in an ethylene trimerization apparatus in situ and ethylene is introduced into the apparatus continuously. The prepared catalyst can be used to synthesize 1-hexene from ethylene trimerization in the inert solvents. The trimerization is performed at 30-150° C. and 0.5-10.0 MPa for 0.1-4 hours. The catalyst has high catalytic activity and high 1-hexene selectivity. During the process of ethylene trimerization, by-product polyethylene does not stick to the apparatus. | 2012-12-06 |
20120310026 | PROCESS FOR PREPARING AN ALKENE - A process for the preparation of an alkene from an oxygenate comprising contacting a reactant feedstream comprising at least one oxygenate reactant and water with a supported heteropolyacid catalyst at a temperature of at least 170° C., wherein the process is initiated using a start-up procedure comprising the following steps: (i) heating the supported heteropolyacid catalyst to a temperature of at least 220° C.; (ii) maintaining the heat-treated supported heteropolyacid catalyst of step (i) at a temperature of at least 220° C. for a time sufficient to remove bound water from the heteropolyacid component of the supported heteropolyacid catalyst; (iii) under an anhydrous atmosphere, reducing the temperature of the heat-treated supported heteropolyacid catalyst of step (ii) to a temperature below 220° C.; and (iv) contacting the supported heteropolyacid catalyst of step (iii) with the reactant feedstream at a temperature of at least 170° C. | 2012-12-06 |
20120310027 | PROTON CONDUCTING MEMBRANE - A reactor comprising a first zone comprising a dehydrogenation catalyst and a second zone separated from said first zone by a proton conducting membrane comprising a mixed metal oxide of formula (I) Ln | 2012-12-06 |
20120310028 | SYSTEM AND PROCESS FOR ALKYLATION - A method for alkylating a hydrocarbon comprising at least one isoparaffin and at least one olefin that includes introducing a liquid catalyst and the hydrocarbon into a high shear device; processing the liquid catalyst and the hydrocarbon in the high shear device to form an emulsion comprising droplets of hydrocarbon dispersed in the liquid catalyst; introducing the emulsion into a vessel operating under suitable alkylation conditions whereby at least a portion of the isoparaffin is alkylated with the olefin to form alkylate, wherein suitable alkylation conditions comprise a bulk reaction temperature of from about 38° C. to about 90° C. and a bulk reaction pressure in the range of from about 1379 kPa to about 34 MPa; and removing a product stream comprising alkylate from the vessel. | 2012-12-06 |
20120310029 | SYSTEM AND METHOD TO MITIGATE MIGRATION OF CONTAMINATES - System and Method is described that slows the release of contaminated water by rapidly freezing the ground water, including salt water, which permeates the area underneath the a contamination source such as a melted reactor, so that the resulting ice lens mitigates the extent to which radioactive water is released into the environment. The method here described may be used for this purpose through the accomplishment of two goals; first, a resulting reduction in the quantum of radioactive water released, per se, and secondly, a reduction in the level of particulate radiation reaching the environment due to slowed water flow velocities. Cooling channels in thermal contact with the water and soil evaporate a low boiling point liquid in order to cool the proximate water and soil. The low boiling point liquid is supplied by an insulated supply channel. The channels are bored into the earth using known boring/tunneling techniques. | 2012-12-06 |
20120310030 | Device And Method For Line Control Of An Energy Beam - The invention relates to the field of line control of a beam, and especially to a device comprising a plurality of ionisation chambers, enabling the measurement of the dose deposited by an ionising beam and the field of said beam. At least one ionisation chamber is formed from support films having a thickness less than or equal to 100 nm. | 2012-12-06 |
20120310031 | SHIELDING ASSEMBLIES FOR INFUSION SYSTEMS - A shielding assembly for an infusion system includes a plurality of compartments and a door for each compartment, and provides a radioactive radiation barrier for the compartments. One of the compartments contains a radioisotope generator of the infusion system and another of the compartments may contain a waste bottle of the infusion system. An opening into each of the generator and waste bottle compartments may be oriented upward, and the opening into the latter may be at a higher elevation than the opening into the former, for example, to facilitate independent removal and replacement of each. A door of at least one of the compartments, other than the generator compartment, when closed, may prevent the door of the generator compartment from being opened. A cabinet structure for the infusion system may enclose the shielding assembly and secure the generator. | 2012-12-06 |
20120310032 | METHODS FOR ASYMMETRICAL IRRADIATION OF A BODY CAVITY - The disclosure describes devices and methods for asymmetrical irradiation at a body cavity or site, such as after removal of tissue, e.g. biopsy or cancer. One device includes a lumen which is off-set or off-settable from a longitudinal axis to increase the intensity of radiation received from a radiation source by a first tissue portion surrounding the body cavity and to reduce or minimize radiation received by a second tissue portion (e.g. healthy tissue) surrounding the body cavity. | 2012-12-06 |
20120310033 | Method for Cosmetic Skin Smoothening and Device Therefor - The invention relates to a method for cosmetic skin smoothening wherein two magnetic fields are generated perpendicular to each other and wherein the field strength of a quasi-static magnetic field or the frequency of an alternating magnetic field is modulated. | 2012-12-06 |
20120310034 | DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS - The present invention relates to a system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator. In one aspect, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels. | 2012-12-06 |
20120310035 | TRANSCRANIAL MAGNET STIMULATION OF DEEP BRAIN TARGETS - The treatment of specific neurological and psychiatric illnesses using Transcranial Magnetic Stimulation (TMS) requires that specific neuroanatomical structures are targeted using specific pulse parameters. Described herein are methods of positioning and powering TMS electromagnets to selectively stimulate a deep brain target region while minimizing the impact on non-target regions between the TMS electromagnet and the target. Use of these configurations may involve a combination of physical, spatial and/or temporal summation. Specific approaches to achieving temporal summation are detailed. | 2012-12-06 |
20120310036 | BLOOD PUMP - A blood pump has a hollow body in which an impeller with a spiral blading produces an axial propulsion of blood along the impeller, as well as an at least partly actively stabilized magnetic bearing device and a hydrodynamic bearing device for the impeller. The impeller may be set into a rotation about a rotation axis of the impeller with a motor stator located outside the hollow body. The hollow body has an inlet for the flow of blood into the hollow body in an inflow direction which is essentially parallel to the rotation axis, and an outlet for the outflow of the blood out of the hollow body in an outflow direction which is offset to the rotation axis of the impeller to produce a non-zero outflow angle (α) between the inflow direction and the outflow direction. A total artificial heart can be formed from two such blood pumps. | 2012-12-06 |
20120310037 | VENTRICULAR ASSIST DEVICE CANNULA AND VENTRICULAR ASSIST DEVICE INCLUDING THE SAME - Provided is a ventricular assist device cannula, and more particularly, a ventricular assist device cannula with electrodes. An exemplary embodiment of the present invention provides a ventricular assist device cannula with electrodes, including: a connecting tube connecting an incision of a body tissue and a ventricular assist device so that blood can flow; and electrodes connected with the connecting tube and contacting the incision of the body tissue to transfer an electric signal to the body tissue. | 2012-12-06 |
20120310038 | Sleep Induction Device and Sleep Induction Method - Disclosed is a sleep induction device which exhibits excellent hypnotic effects using light rather than ultrasonic waves or electrical voltages to induce sleep. When the face of a patient is irradiated with diffused ultra narrow band light having a FWHM of 10 nm or less, the specified wavelength of light has excellent hypnotic effects. The sleep induction device is provided with: an ultra narrow band light irradiation means which generates a blue to green ultra narrow band light having a FWHM of 10 nm or less and a peak wavelength range of 430-550 nm; and a diffusion means for reducing the illumination intensity of the light irradiated from the ultra narrow band light irradiation means onto the skin surface of the face to 1-300 lux, and expanding the emission area to the entire face. The green ultra narrow band light has a sleep-inducing effect, and the blue one has a stronger sleep-inducing effect. | 2012-12-06 |
20120310039 | INCONTINENCE TREATMENT DEVICE - An incontinence treatment device includes a urethral support and first and second connectors. The urethral support extends between a first end and a second end and has porosity that is configured to allow tissue in-growth through the urethral support. The first connector is attached to the first end of the urethral support and the second connector is attached to the second end of the urethral support. At least one of the first connector and the second connector is a cross-linked polymer connector having a glass transition temperature between 40-70 degrees Celsius. The cross-linked polymer connector has an initial length that is elongated to an implant length that is greater than the initial length. Means for heating the cross-linked polymer connector from an extracorporeal location through intact skin is provided, thereby shortening the cross-linked polymer connector. | 2012-12-06 |
20120310041 | Percutaneously Implantable Replacement Heart Valve Device and Method of Making Same - A method of making a replacement heart valve device whereby a fragment of biocompatible tissue material is treated and soaked in one or more alcohol solutions and a solution of glutaraldehyde. The dried biocompatible tissue material is folded and rehydrated in such a way that forms a two- or three-leaflet/cusp valve without affixing of separate cusps or leaflets or cutting slits into the biocompatible tissue material to form the cusps or leaflets. After the biocompatible tissue material is folded, it is affixed at one or more points on the outer surface to the inner cavity or a stent. | 2012-12-06 |
20120310042 | APPARATUS AND METHOD FOR REAL-TIME IMAGING AND MONITORING OF AN ELECTROSURGICAL PROCEDURE - An optical coherence tomography probe and laser combination device configured for real-time z-directional guidance of the incisional depth of a surgical procedure. It can be used alone or placed within the working channel of an endoscope. The device includes an OCT single mode fiber, and a laser fiber or laser hollow waveguide or electrical surgical wire positioned adjacent to the OCT single mode fiber. The single mode fiber is configured to move laterally when activated by an actuator to scan light data reflected from a sample that is positioned in front of a distal end of the device. The light data can be processed to generate a B-scan image. The device can collect data in real-time during lasing, or immediately prior to and following the cutting. The surgical tool, when coupled to a processor, can deactivate when the B-scan image identifies that the incision is within a predefined tolerance. | 2012-12-06 |
20120310043 | STRUCTURE OF IMAGING PART IN ELECTRONIC VISUALIZED CATHETER - An imaging part of an electronic visualized catheter including, an object lens system, and a solid state imaging element which is positioned to receive light output from the object lens system and which photoelectrically converts the light output from the object lens system into an electric signal, wherein an output lens face of the object lens system is planar, and the output lens face is joined to a light receiving surface of the solid state imaging element. | 2012-12-06 |
20120310044 | ENDOSCOPIC VISION SYSTEM - The present invention relates to an endoscopic visioning system and related method for both forward and backward viewing of a body lumen. According to an embodiment, the system includes an endoscope, a vision head including a light source and a vision chip on both a proximal and a distal side of the vision head, and an extension arm for moving the vision head away from and back toward the endoscope. Alternatively, the light source and vision chip may be contained in a distal end of the endoscope. In such an alternative embodiment, the vision head is a parabolic mirror mounted on the extension arm for reflecting images, for example, from behind the distal end of the endoscope to the vision chip in the distal end of the endoscope to permit, for example, a retrograde view of the surgical site entrance. | 2012-12-06 |
20120310045 | ELECTRONIC ENDOSCOPE - An electronic endoscope of the present invention includes an elongated insertion portion inserted into a subject, a distal end of the elongated insertion portion including a solid state imaging device, an operating portion connected to an other end of the insertion portion so as to be freely attachable thereto or detached therefrom, and an interface substrate that processes RAW data obtained by the solid-state imaging device and that creates and outputs image signals. At least part of an interface substrate is disposed inside the operating portion, and a first electrical cable that transmits the RAW data obtained by the solid-state imaging device is connected to a connector located on the interface substrate or located on the way toward the interface substrate, and when the insertion portion is being attached to or detached from the operating portion, the first electrical cable is attached or detached at a connector portion. | 2012-12-06 |
20120310046 | SYSTEMS FOR REDUCING FLUID LEAKAGE AND SPRAY-BACK FROM ENDOSCOPIC MEDICAL PROCEDURES - Assemblies and methods of inserting a delivery catheter assembly into a working channel are disclosed. In accordance with some embodiments, a delivery catheter assembly is disclosed in which a tip protector sleeve is locked onto an elongated catheter sheath and slideable over a length of the elongated catheter sheath between a proximal-stop position and a distal-stop position along the elongated catheter sheath. In accordance with some embodiments, a sealing cap is disclosed in which a proximal seal of the sealing cap is configured to reduce fluid leakage when a delivery system is inserted through the proximal seal, and a self closing seal of the sealing cap is configured to reduce fluid leakage when a delivery system is not inserted into the sealing cap. | 2012-12-06 |
20120310047 | LIGHT SOURCE APPARATUS - A light source apparatus includes a first light source for emitting first light which is inputted to alight guide section that guides light to an examination area and projects the light onto the examination area and a second light source for emitting second light which is inputted to the light guide in which exit angles of the first and second light are changed simultaneously by an exit angle changing section, the first and second light being guided by the light guide section and projected onto the examination area. | 2012-12-06 |
20120310048 | EXPANDING CONDUITS - A device comprising an elongated conduit comprising further at least an upper profile and at least a lower profile is disclosed. The upper and lower profiles being relatively displaceable such that when a distal part of the conduit is deployed between two regions of tissue, a spacing between an upper distal surface of the upper profile and a lower distal surface of the lower profile can be varied, thereby opening a space between the two regions of tissue, and wherein the upper and lower profiles are further configured so as to define therebetween a working channel to provide access to the space between the two regions of tissue through the conduit. | 2012-12-06 |
20120310049 | Medical Access Device Having A Protection Against An Excessive Application Of Leverage - A medical access device for creating an access to a body for minimally invasive intervention has a hollow body assembled from at least two parts having longitudinal extending edges. Each part has a distal body portion and at an angle to the latter a proximal body portion. A locking mechanism locks the assembled proximal hollow body portions. The locking mechanism has a hook projecting from an edge of a proximal body. A nose of the hook can enter from proximal to distal in a recess in an edge joining said edge having said hook. | 2012-12-06 |
20120310050 | Detecting, Assessing and Managing Epilepsy Using a Multi-Variate, Metric-Based Classification Analysis - A method for identifying changes in an epilepsy patient's disease state, comprising: receiving at least one body data stream; determining at least one body index from the at least one body data stream; detecting a plurality of seizure events from the at least one body index; determining at least one seizure metric value for each seizure event; performing a first classification analysis of the plurality of seizure events from the at least one seizure metric value; detecting at least one additional seizure event from the at least one determined index; determining at least one seizure metric value for each additional seizure event, performing a second classification analysis of the plurality of seizure events and the at least one additional seizure event based upon the at least one seizure metric value; comparing the results of the first classification analysis and the second classification analysis; and performing a further action. | 2012-12-06 |
20120310051 | Systems And Methods For Signal Rephasing Using The Wavelet Transform - Methods and systems are disclosed for defining a physiological parameter. A first physiological signal is transformed into in a complex transform space, the transformed signal having a magnitude and a phase. The transformed signal is rotated by altering its phase. The rotated signal is inverted, and the inverted signal is aligned in phase with a second physiological signal. The aligned inverted signal and the second physiological signal are combined to form a combined signal indicative of the physiological parameter. | 2012-12-06 |
20120310052 | SYSTEMS AND METHODS FOR DETERMINING LOCATION OF AN ACCESS NEEDLE IN A SUBJECT - Systems and methods for epicardial electrophysiology and other procedures are provided in which the location of an access needle may be inferred according to the detection of different pressure frequencies in separate organs, or different locations, in the body of a subject. Methods may include inserting a needle including a first sensor into a body of a subject, and receiving pressure frequency information from the first sensor. A second sensor may be used to provide cardiac waveform information of the subject. A current location of the needle may be distinguished from another location based on an algorithm including the pressure frequency information and the cardiac waveform information. | 2012-12-06 |
20120310053 | MEDICAL INSTALLATION, AND METHOD FOR CONTROLLING A MEDICAL APPARATUS THEREIN - In a method to control a medical apparatus of an installation having: a contact device for a patient, at least one electrical potential sensor that can be coupled to the body of said patient is integrated into the contact device. A signal evaluation device is provided with measurement signals generated with the electrical potential sensor for evaluation. The medical apparatus is connected with the signal evaluation device, and measurement signals that relate to the breathing and/or cardiac activity of the patient are acquired with the at least one electrical potential sensor coupled to the body of said patient upon contact of the patient with the contact device. Trigger signals are generated with the signal evaluation device based on the measurement signals that relate to the breathing cycle and/or the cardiac cycle of the patient. Operation of the medical apparatus is controlled based on the trigger signals. | 2012-12-06 |
20120310054 | BOLUS - A bolus, for introduction into a ruminant animal's reticulum to register pressure signals transmitted through fluids therein, has a case unit adapted for immersion in the fluids. A mechanical amplifier element extends out from the case unit and is adapted to be surrounded by the fluids in the reticulum and absorb mechanical energy from the pressure signals. A guide part conveys mechanical energy from the mechanical amplifier element to a sensor module in the interior of the case unit. The sensor module transduces the pressure signals into electric signals from which a processing module extracts data representing body movements, a heart beat rate, a respiratory rate, a respiratory depth and/or stomach activity of the animal. A communication module in the case unit receives the data and transmits output radio signals reflecting the data. | 2012-12-06 |
20120310055 | ULTRA-WIDE BAND NON-INVASIVE BIOLOGICAL SENSOR AND METHOD - The disclosure provides an electromagnetic (EM) sensor system and method that permits rapid and non-invasive measurement of blood glucose or other biological characteristics that exhibits a unique spectral signature, such as its complex electrical permittivity within the frequency range from near DC to microwave frequencies. Low-level EM signals are coupled through the skin and modified by electrical properties of the sub dermal tissues. These tissues essentially integrate with the sensor circuit as they interact with the transmitted EM energy. The guided-wave signal can be sampled and converted to a digital representation. The digital information can be processed and analyzed to determine the frequency-sensitive permittivity of the tissues and a determination of blood glucose level is made based upon the sensor output. The sensor design and method has wide-ranging applicability to a number of important measurement problems in industry, biology, medicine, and chemistry, among others. | 2012-12-06 |
20120310056 | Peritoneal dialysis system - The invention relates to a peritoneal dialysis sampling system to be used together with a peritoneal dialysis system which is programmed to deliver fluid to a peritoneal cavity of a patient and to drain the fluid from the cavity, said peritoneal dialysis system comprising a supplying line and supplying means for supplying dialysis fluid to the peritoneal cavity, a draining line and draining means for draining the fluid from the cavity, said peritoneal dialysis sampling system comprising an automatic sampling system which is able to automatically sample volumic fractions of the dialysate contained in the peritoneum of the patient at specific time intervals in order to evaluate the peritoneal membrane characteristics and/or improve the peritoneal dialysis for a given patient. | 2012-12-06 |
20120310057 | METHOD FOR EVALUATING VASCULAR ENDOTHELIUM FUNCTION AND A SYSTEM THEREFOR - A method for evaluating vascular endothelium function in a human subject comprises monitoring changes in intensity of NADH fluorescence signal emitted from skin tissue cells of an upper limb of said subject as a function of time, wherein said changes result from reactive hyperaemia caused by blocking and releasing blood flow in the same upper limb of said subject. A system for evaluating vascular endothelium function in a human subject comprises a means for illuminating a skin on an upper limb of said subject with exciting light, a means for measuring intensity of fluorescence signal emitted from the skin and recording changes of said intensity of the fluorescence signal over time; and a restriction means for blocking and releasing blood flow in the upper limb of said subject. | 2012-12-06 |
20120310058 | PHOTON DENSITY WAVE BASED DETERMINATION OF PHYSIOLOGICAL BLOOD PARAMETERS - A system for measuring a physiological parameter of blood in a patient is presented. The system includes a transmission module configured to emit a plurality of photon density waves into tissue of the patient from a plurality of modulated light sources. The system also includes a receiver module configured to detect characteristics of the plurality of photon density waves. The system also includes a processing module configured to identify characteristics of a pulsatile perturbation of the tissue based on the characteristics of the plurality of photon density waves, and identify a value of the physiological parameter based on at least the characteristics of the pulsatile perturbation of the tissue and the characteristics of the plurality of photon density waves. | 2012-12-06 |
20120310059 | Clinical Acceptance Tool - Provided herein are methods and apparatuses for facilitating clinical acceptance of patient monitoring features. These methods may be used in conjunction with a computer that includes software for viewing the type of display associated with the monitoring feature. The clinical acceptance systems as provided herein may display a new or experimental monitoring feature along with a benchmark feature that a clinician is familiar with. In certain embodiments, the viewing tool may be isolated from the calculation tools so that the computer may include stored files that are in a format ready for display. | 2012-12-06 |
20120310060 | METHOD OF ANALYZING PHOTON DENSITY WAVES IN A MEDICAL MONITOR - A monitoring system may include an emission feature capable of emitting light into tissue, a modulator capable of modulating the emitter at a modulation frequency, e.g., in a range of about 10 MHz to 3.0 GHz, to generate resolvable photon density waves, a detection feature capable of detecting photons of the photon density waves after passage through the tissue, and a processor capable of using phase and amplitude differences of the photon density wave signal relative to a reference to determine one or more physiological parameters. The phase and amplitude differences may be much lower frequency that the modulation rate. Accordingly, these differences may be masked by signal artifacts. Provided herein are signal conditioning techniques that may improve the signal to noise ratio of photon density wave signals and yield a more robust phase and amplitude signal. | 2012-12-06 |
20120310061 | NONINVASIVE OXIMETRY OPTICAL SENSOR INCLUDING DISPOSABLE AND REUSABLE ELEMENTS - A pulse oximetry sensor includes reusable and disposable elements. To assemble the sensor, members of the reusable element are mated with assembly mechanisms of the disposable element. The assembled sensor provides independent movement between the reusable and disposable elements. | 2012-12-06 |
20120310062 | PHOTON DENSITY WAVE BASED DETERMINATION OF PHYSIOLOGICAL BLOOD PARAMETERS - A method for measuring a physiological parameter of blood in a patient is presented. The method includes emitting light from a modulated light source into tissue of the patient to generate a photon density wave in the tissue, detecting the photon density wave during pulsatile perturbation of the tissue, and processing an amplitude and phase of the photon density wave over the pulsatile perturbation to determine a value of the physiological parameter. | 2012-12-06 |